Psychopharmacology and Psychiatry Updates

Un podcast de Psychopharmacology Institute

Catégories:

242 Épisodes

  1. Preventing Depression and Anxiety Relapse in Youth

    Publié: 01/05/2024
  2. Charting the Clozapine Course: Titration and Monitoring

    Publié: 26/04/2024
  3. Smoking and Psychosis: Insights from the PATH Study

    Publié: 21/04/2024
  4. Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia

    Publié: 16/04/2024
  5. Balancing Benefits and Risks: Lithium in Child and Adolescent Psychiatry

    Publié: 11/04/2024
  6. Orchestrating Nutrition and Medication: Micronutrient Therapy in Practice

    Publié: 06/04/2024
  7. Zuranolone: A New Dawn for Postpartum Depression Treatment

    Publié: 01/04/2024
  8. Micronutrients for Psychiatric Disorders: Optimizing Clinical Use

    Publié: 27/03/2024
  9. Olanzapine in Pregnancy: Examining the Risks

    Publié: 22/03/2024
  10. Understanding Safety Risks of Broad-Spectrum Micronutrients

    Publié: 17/03/2024
  11. The Role of Inflammation in Delirium: Can NSAIDs Help?

    Publié: 12/03/2024
  12. Beyond Medication: Exploring Nutritional Psychiatry

    Publié: 07/03/2024
  13. Age Impact on Antidepressant Outcomes

    Publié: 02/03/2024
  14. Dealing With Delirium in Patients With Advanced Cancer

    Publié: 26/02/2024
  15. Rechallenging Clozapine: A Look at Colony Stimulating Factors

    Publié: 21/02/2024
  16. Managing Anxiety in Patients With Cancer

    Publié: 16/02/2024
  17. Managing Antidepressant Side Effects in Youth

    Publié: 11/02/2024
  18. Depressed Patient With Cancer? Here’s How to Treat

    Publié: 06/02/2024
  19. Brexanolone: A Quick Fix for Postpartum Depression and Anxiety?

    Publié: 01/02/2024
  20. The Nitty-Gritty on Treatment Optimization for Tic Disorders in Youth

    Publié: 27/01/2024

3 / 13

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site